Wall Street Experts
ver. ZuMIgo(08/25)
Atea Pharmaceuticals, Inc.
Rachunek Zysków i Strat
Przychody TTM (mln): 0
EBIT TTM (mln): -193
index |
0 |
1 |
2 |
3 |
4 |
5 |
6 |
Rok finansowy |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
Przychód (mln) |
0 |
0 |
49 |
351 |
0 |
0 |
0 |
Przychód Δ r/r |
0.0% |
0.0% |
inf% |
622.5% |
-100.0% |
0.0% |
0.0% |
Marża brutto |
0.0% |
-inf% |
100.0% |
100.0% |
-inf% |
-inf% |
0.0% |
EBIT (mln) |
-9 |
-15 |
-11 |
138 |
-131 |
-164 |
-193 |
EBIT Δ r/r |
0.0% |
54.1% |
-24.5% |
-1354.6% |
-194.4% |
25.7% |
17.5% |
EBIT (%) |
0.0% |
0.0% |
-22.7% |
39.4% |
0.0% |
0.0% |
0.0% |
Koszty finansowe (mln) |
0 |
0 |
0 |
0 |
11 |
0 |
0 |
EBITDA (mln) |
-9 |
-15 |
-11 |
138 |
-131 |
-164 |
-193 |
EBITDA(%) |
0.0% |
0.0% |
-22.6% |
39.4% |
0.0% |
0.0% |
0.0% |
Podatek (mln) |
0 |
-1 |
-0 |
17 |
-4 |
1 |
-1 |
Zysk Netto (mln) |
-9 |
-13 |
-11 |
121 |
-116 |
-136 |
-168 |
Zysk netto Δ r/r |
0.0% |
48.5% |
-19.3% |
-1215.5% |
-195.6% |
17.3% |
23.9% |
Zysk netto (%) |
0.0% |
0.0% |
-22.3% |
34.5% |
0.0% |
0.0% |
0.0% |
EPS |
-0.19 |
-0.16 |
-0.13 |
1.46 |
-1.39 |
-1.63 |
-2.0 |
EPS (rozwodnione) |
-0.19 |
-0.16 |
-0.13 |
1.37 |
-1.39 |
-1.63 |
-2.0 |
Ilośc akcji (mln) |
47 |
83 |
82 |
83 |
83 |
83 |
84 |
Ważona ilośc akcji (mln) |
47 |
83 |
82 |
88 |
83 |
83 |
84 |
Waluta |
USD |
USD |
USD |
USD |
USD |
USD |
USD |